Pfizer gives up the chase.

Pfizer is saying today that it does not intend to extend a firm offer for AstraZeneca, bringing an end to its attempt to acquire the UK drug maker.  AZ shareholders were split on the latest offer, and a stumble by AZ would probably bring many of them back to the negotiating table.  Per UK securities law, a six month month cooling off period now follows. I’m guessing Pfizer will be waiting, and watching.

Advertisements
This entry was posted in Pharmaceutical Industry and tagged , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s